Steven Cohen's GMAB Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 135,647 shares of Genmab A/S (GMAB) worth $3.73 M, representing 0.00% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in GMAB, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 835,721 shares. Largest reduction occurred in Q3 2025, reducing 538,500 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Genmab A/S (GMAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Genmab A/S (GMAB) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +135,647 | New Buy | 135,647 | $27.47 |
| Q3 2025 | -538,500 | Sold Out | 0 | $0.00 |
| Q2 2025 | -385,367 | Reduce 41.71% | 538,500 | $20.66 |
| Q1 2025 | +835,721 | Add 948.11% | 923,867 | $19.58 |
| Q4 2024 | +88,146 | New Buy | 88,146 | $20.87 |
| Q3 2024 | -18,184 | Sold Out | 0 | $0.00 |
| Q2 2024 | +18,184 | New Buy | 18,184 | $25.13 |
| Q1 2024 | -101,100 | Sold Out | 0 | $0.00 |
| Q4 2023 | -177,501 | Reduce 63.71% | 101,100 | $31.84 |
| Q3 2023 | +101,101 | Add 56.96% | 278,601 | $35.27 |
| Q2 2023 | -83,266 | Reduce 31.93% | 177,500 | $38.01 |
| Q1 2023 | +260,766 | New Buy | 260,766 | $37.76 |
| Q4 2021 | -56,600 | Sold Out | 0 | $0.00 |
| Q3 2021 | -385,000 | Reduce 87.18% | 56,600 | $43.69 |
| Q2 2021 | +212,900 | Add 93.09% | 441,600 | $40.83 |
| Q1 2021 | +228,700 | New Buy | 228,700 | $32.83 |
Steven Cohen's Genmab A/S Investment FAQs
Steven Cohen first purchased Genmab A/S (GMAB) in Q1 2021, acquiring 228,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Genmab A/S (GMAB) for 16 quarters since Q1 2021.
Steven Cohen's largest addition to Genmab A/S (GMAB) was in Q1 2025, adding 923,867 shares worth $18.09 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 135,647 shares of Genmab A/S (GMAB), valued at approximately $3.73 M.
As of the Q2 2026 filing, Genmab A/S (GMAB) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Genmab A/S (GMAB) was 923,867 shares, as reported at the end of Q1 2025.